Researchers at the University of British Columbia and Switzerland’s Paul Scherrer Institut have come up with a microneedle that can painlessly measure drugs in…

The National Comprehensive Cancer Network is recommending Novocure’s Optune to treat newly diagnosed glioblastoma in combination with temozolomide, a standard…

Royal Philips is doing alright for itself, per earnings discussed during a recent call. This boost seems to be thanks to the multitude of acquisitions Philips…

DeepMind--a Google-owned AI company--has decided to suspend use of its Streams app.

Newron Pharmaceuticals has seen a much-needed quick turnaround for its lead Parkinson’s drug as it can now resubmit its candidate in the U.S.--just four months…

The U.K.’s Cytox announced it launched the research use of its variaTECT genetic biomarker test for assessing the risk of Alzheimer’s disease.

The first spinoff from Cydan, an orphan disease incubator created by Pfizer Ventures and New Enterprise Associates, has nabbed $17 million to bump up its…

Tandem Diabetes Care and TypeZero Technologies have entered into an agreement to bring together TypeZero’s artificial pancreas tech and Tandem’s t:slim Insulin…